scieee Open visual document viewer

Caffeine intake exerts dual genome-wide effects on hippocampal metabolism and learning-dependent transcription

Paiva, Isabel,Cellai, Lucrezia,Meriaux, Céline,Poncelet, Lauranne,Nebie, Ouada,Saliou, Jean-Michel,Lacoste, Anne-Sophie,Papegaey, Anthony,Drobecq, Hervé,Le Gras, Stéphanie,Schneider, Marion,Malik, Enas M,Müller, Christa E.,Faivre, Emilie,Carvalho, Kevin,

Abstract

This work was supported by grants from Hauts-de-France (PARTEN-AIRR, COGNADORA; START-AIRR, INS-SPECT) and Programs d’Investissements d’Avenir LabEx (excellence laboratory) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer’s disease) and EGID (European Genomic Institute for Diabetes ANR-10LABX-46). Our laboratories are also supported by ANR (GRAND to LB, ADORATAU, ADORASTrAU, METABOTAU to DB and BETAPLASTICITY to JSA), COEN (5008), Fondation pour la Recherche Médicale, France Alzheimer/Fondation de France, FHU VasCog research network (Lille, France), Fondation Vaincre Alzheimer (ADOMEMOTAU), European Foundation for the Study of Diabetes (EFSD to JSA), Fondation Plan Alzheimer as well as Inserm, CNRS, Université Lille, Lille Métropole Communauté Urbaine, DN2M. KC hold a doctoral grant from Lille University. VG-M was supported by Fondation pour la Recherche Médicale (SPF20160936000). CM was supported by Région Hauts753 30 754 de-France. ALB is supported by CNRS, Unistra (Strasbourg, France), ANR-16-CE92-0031 755 756 757 758 759 760 761 762 (EPIFUS), ANR-18-CE16-0008-02 (ADORASTrAU), Alsace Alzheimer 67, France Alzheimer (AAP SM 2017 #1664). IP is supported by Fondation pour la Recherche Médicale (SPF201909009162). CEM is grateful for the support by the Alzheimer Forschung Initiative e.V. (AFI, Düsseldorf, Germany). LC was funded by SIF Italian Society of Pharmacology. RAC was supported by LaCaixa Foundation (LCF/PR/HP17/52190001) and FCT (POCI-01-0145-FEDER-03127). Santa Casa da Misericórdia (MB-7-2018) and CEECIND/01497/2017 to LVL.

Full text

1 Ca eine in ake exe s dual genome-wide e ec s on hippocampal me abolism 1 and lea ning-dependen ansc ip ion 2 3 Isabel Pai a1†, Luc ezia Cellai2,3†, Céline Me iaux2,3†, Lau anne Poncele 4†, Ouada Nebie2,3, Jean- 4 Michel Saliou5, Anne-Sophie-Lacos e5, An hony Papegaey2,3, He é D obecq6, S éphanie Le G as7, 5 Ma ion Schneide 8, Enas M. Malik8, Ch is a E. Mülle 8, Emilie Fai e2,3, Ke in Ca alho2,3, Vic o ia 6 Gomez-Mu cia2,3, Didie Vieau2,3, B yan Thi oux2,3, Sabiha Edda kaoui2,3, Thibaud Lebou ie 2,3,9, 7 Es elle Schuelle 1, Lau a Tzeplae 1, I is G gu ina1, Jona han Seguin1, Jona han S aube 4, Luisa V. 8 Lopes10, Luc Buée2,3, Valé ie Buée-Sche e 2,3, Rod igo A. Cunha11,12, Rima Ai -Belkacem4‡, Nicolas 9 Se gean 2,3‡, Jean-Sébas ien Annico e13,14‡, Anne-Lau ence Bou illie 1‡*, Da id Blum2,3‡* 10 11 12 † Equal con ibu ions 13 ‡ Equal con ibu ions 14 15 1. Uni e si y o S asbou g, CNRS, UMR7364 - Labo a oi e de Neu oscience Cogni i es e 16 Adap a i es (LNCA), F-67000 S asbou g, F ance. 17 2. Uni e si y o Lille, Inse m, CHU Lille, UMR-S1172 LilNCog - Lille Neu oscience & Cogni ion, Lille, 18 F ance. 19 3. Alzheime and Tauopa hies, LabEx DISTALZ, F ance. 20 4. ImaBio ech SAS, Pa c Eu asan é, F-59120 Loos, F ance. 21 5. Uni . Lille, CNRS, Inse m, CHU Lille, Ins i u Pas eu de Lille, UAR CNRS 2014 - US Inse m 41 - 22 PLBS, F-59000 Lille, F ance 23 6. CIIL - Cen e d’In ec ion e d’Immuni é de Lille (CIIL) - INSERM U1019 - UMR 9017 24 7. Uni . S asbou g, CNRS UMR7104, Inse m U1258 - GenomEas Pla o m – IGBMC - Ins i u de 25 Géné ique e de Biologie Moléculai e e Cellulai e, F-67404 Illki ch, F ance. 26 8. Pha maCen e Bonn, Pha maceu ical Ins i u e, Pha maceu ical & Medicinal Chemis y, Uni e si y 27 o Bonn, D-53121 Bonn, Ge many. 28 9. CHU Lille, Memo y Clinic, Lille F ance. 29 10. Ins i u o de Medicina Molecula , Faculdade de Medicina de Lisboa, Uni e sidade de Lisboa, 30 Lisbon, Po ugal. 31 11. CNC - Cen e o Neu oscience and Cell Biology, Uni e si y o Coimb a, 3004-504 Coimb a, 32 Po ugal. 33 12. Facul y o Medicine, Uni e si y o Coimb a, 3004-504 Coimb a, Po ugal. 34 13. Uni . Lille, INSERM, CNRS, CHU Lille, Ins i u Pas eu de Lille, Inse m U1283 / CNRS UMR8199 35 - EGID, 59000 Lille, F ance. 36 14. Uni . Lille, INSERM, CHU Lille, Ins i u Pas eu de Lille, U1167 – RID-AGE-Fac eu s de isque 37 e dé e minan s moléculai es des maladies liées au ieillissemen , 59000 Lille, F ance. 38 39 40 # Co espondence o: 41 Da id Blum, Inse m UMR-S1172, “Alzheime & Tauopa hies”, Place de Ve dun, 59045, Lille Cedex, 42 F ance. O cid Numbe : 0000-0001-5691-431X. Tel: +33320298850, Fax: +33320538562. 43 da id.blum@inse m. 44 Anne-Lau ence Bou illie , Labo a oi e de Neu oscience Cogni i es e Adap a i es (LNCA), 45 UMR7364 Cn s Unis a, 67000 S asbou g, F ance. O cid Numbe : 0000-0002-2317-928.0 46 lau e[email p o ec ed] 47 48 49 Con lic o in e es . The au ho s ha e decla ed ha no con lic o in e es exis s. 50 2 Abs ac 51 52 Ca eine is he mos consumed psychoac i e subs ance wo ldwide. S ikingly, molecula pa hways 53 engaged by i s egula consump ion emain unclea . We he ein add essed he mechanisms 54 associa ed wi h habi ual (ch onic) ca eine consump ion in he mouse hippocampus using un a ge ed 55 o hogonal-omics echniques. Ou esul s e ealed ha ch onic ca eine exe s conce ed pleio opic 56 e ec s in he hippocampus, a he epigenomic, p o eomic and me abolomic le els. Ca eine lowe s 57 me abolic- ela ed p ocesses in he bulk issue, while i induces neu onal-speci ic epigene ic changes 58 a synap ic ansmission/plas ici y- ela ed genes and inc eased expe ience-d i en ansc ip ional 59 ac i i y. Al oge he , hese indings sugges ha egula ca eine in ake imp o es he signal- o-noise 60 a io du ing in o ma ion encoding, in pa h ough a ine- uning o me abolic genes while boos ing he 61 salience o in o ma ion p ocessing du ing lea ning in neu onal ci cui s. 62 63 64 65 66 3 In oduc ion 67 68 Ca eine is he mos consumed psychoac i e subs ance wo ldwide (abou 80% o he popula ion) ia 69 die a y in ake om co ee, ea and soda be e ages. I s popula i y de i es om i s abili y o enhance 70 well-being and some cen al- ela ed unc ions such as a en ion and ale ness (1). La ge 71 epidemiological s udies poin ou an in e se associa ion be ween co ee/ca eine consump ion and 72 all-cause mo ali y (2–4). In gene al, he impac o ca eine on human heal h ollows an in e ed bell- 73 shaped dose- esponse cu e wi h bene i s obse able a doses o 200-400 mg pe day, ha can be 74 ecapi ula ed by 0.3 g/L p.o. in oden s. 75 Compelling epidemiological and expe imen al e idence suppo ha habi ual/ch onic ca eine 76 consump ion no malizes synap ic plas ici y and cogni i e decline in al e ed allos a ic si ua ions such 77 as ageing, Alzheime ’s disease o o he neu o-psychia ic condi ions (5–7). A mo e limi ed numbe 78 o s udies howe e also suppo ha , independen ly o i s abili y o a o a ousal and a en ion, 79 ca eine may exhibi cogni i e-enhancing p ope ies. A e being ewa ded wi h ca eine, honeybees 80 a e able o emembe a p e iously lea ned lo al scen (8). Also, acu e ca eine adminis a ion in a s 81 can enhance memo y es pe o mance (9, 10). In Humans, ca eine in ake immedia ely ollowing 82 lea ning imp o es disc imina ion pe o mance 24 hou s la e (11). These esul s a e in line wi h 83 obse a ions suppo ing he abili y o ca eine o modula e hippocampal/co ical exci abili y in 84 homeos a ic condi ions. Indeed, ca eine ea men in hippocampal slices enhances basal synap ic 85 ansmission (12–14) and modula es long- e m po en ia ion (LTP) in oden s’ hippocampus (12, 15, 86 16) and sha p wa e ipple complexes, ha a e p oposed o unde lie memo y consolida ion (17). 87 Ca eine also con ols neu onal exci abili y and LTP-like e ec s in he human co ex (18, 19). Mos 88 o hese s udies howe e ely on acu e adminis a ions wi h limi ed ele ance owa ds 89 habi ual/ch onic consump ion. 90 Despi e ca eine’s popula i y, b ain molecula changes associa ed wi h i s ch onic in ake emain ill- 91 de ined. Ca eine is known o essen ially in e e e wi h he adenosine gic sys em whe e i ac s as an 92 4 an agonis (20). Howe e , adap i e downs eam pa hways engaged by habi ual/ch onic ca eine 93 consump ion ha e been la gely o e looked. In he p esen s udy, we used a combina ion o unbiased 94 o hogonal-omics echniques o analyze he epigenome, ansc ip ome, p o eome and me abolome 95 o he mouse hippocampus in o de o unco e he molecula pa hways impac ed by ch onic ca eine 96 consump ion in neu onal p ocessing du ing lea ning. 97 98 5 Resul s 99 100 Mouse moni o ing and ca eine concen a ions. In ou expe imen al condi ions, nei he mo ali y 101 no signs o animal su e ing in ca eine- ea ed animals we e encoun e ed. A e age consump ion o 102 0.3 g/L ca eina ed wa e was 4.83 ± 0.15 mL/mouse/day esul ing in b ain ca eine concen a ions 103 o 3.6 ± 1.1 µM, co esponding o a mode a e in ake in Humans (20). Ca eine me aboli es 104 (pa axan hine, heob omine and heophylline) we e also de ec ed in he b ain o ea ed mice wi h 105 espec i e concen a ions o 1.9 ± 0.4 µM, 1.8 ± 0.3 µM, and 0.10 ± 0.03 µM (n=5). 106 107 Ch onic ca eine consump ion dec eases his one ace yla ion o me abolic- ela ed genes in 108 he hippocampus. We hypo hesized ha ch onic ca eine consump ion could a ec hippocampal 109 epigenome o mice. As ca eine is a psychos imulan , we ocused on wo ch oma in ma ks 110 associa ed wi h “ac i e ch oma in” and speci ic ansc ip ional s a es. His one H3 ace yla ion a lysine 111 27 (H3K27ac) is p e e en ially en iched a ac i e enhance s (21), also o ming la ge clus e s o 112 H3K27ac-en iched enhance s known as “supe -enhance s” on highly ansc ibed genes ha a e cell- 113 o issue-speci ic (22, 23). His one H3 lysines K9 and K14 (H3K9/K14ac), on which ace yla ion co- 114 occu s a many gene egula o y elemen s, allows o di e en ia e ac i e enhance s om inac i e ones 115 and hus ep esen s a dynamic ma k accoun ing o s imuli dependen ac i a ion (24). Locus speci ic 116 ace yla ion was e alua ed by ch oma in immunop ecipi a ion ollowed by sequencing (ChIP-seq) 117 expe imen s in do sal hippocampus o con ol (wa e ) and ca eine- ea ed mice. A o al o 2 biological 118 eplica es we e pe o med and P incipal Componen Analysis (PCA) o he wo his one ma ks was 119 gene a ed (Supplemen al Figu e 1A,B). Ch onic ca eine in ake signi ican ly dec eased he 120 ace yla ion o bo h his one ma ks a many genomic loci. H3K9/14ac was deple ed in 778 genomic 121 egions (768 genes) while only 3 we e a ely iden i ied as signi ican ly en iched in ca eine- ea ed 122 animals (FDR<1E-5) (Figu e 1A, Supplemen al Table 1). Gene on ology analysis using Genomic 123 6 Regions En ichmen o Anno a ions Tool (GREAT) e ealed ha hese ace yla ion-deple ed egions 124 we e associa ed wi h genes in ol ed in he egula ion o me abolic p ocesses (amide, lipids), mRNA 125 anspo , egula ion o ansla ion and dend i ic spine mo phogenesis and de elopmen (Figu e 1B). 126 A mo e obus e ec was obse ed in H3K27ac whose peaks we e ound dec eased in 2105 genomic 127 egions (1766 genes) and inc eased in only 4 genomic egions in ca eine s. con ol mice (FDR<1E- 128 5) (Figu e 1C, Supplemen al Table 2). Me abolic- ela ed pa hways, such as lipid ca abolic o amide 129 me abolic p ocesses we e among he dec eased peaks o bo h his one ma ks (Figu e 1B,D). 130 Addi ionally, H3K27ac-deple ed egions we e signi ican ly associa ed wi h myelin- ela ed p ocesses, 131 MAP kinase, nega i e egula ion o calcium-media ed signaling pa hways, as well as 132 he e och oma in o ganiza ion (Figu e 1D). We also pe o med Kyo o Encyclopedia o Genes and 133 Genomes (KEGG) pa hway analyses and iden i ied many p ocesses, some o which ela ed o 134 cAMP-, MAP kinase, Rap1-signaling pa hways and ci cadian en ainmen o bo h H3K9/14 and 135 H3K27ac deple ed egions (Figu e 1E). O no e, he KEGG pa hway da abase poin ed ou me abolic- 136 ela ed pa hways, such as “insulin signaling”, o genes deple ed in ace yla ion o bo h his one ma ks 137 (Figu e 1E) and “glucagon signaling pa hway” o hose associa ed wi h H3K9/14ac deple ed egions 138 (Figu e 1E, blue ba s). Those genes associa ed wi h insulin and glucagon signaling pa hways we e 139 ep esen ed by p o ein-p o ein in e ac ion ne wo k analysis (STRING), showing s ong 140 in e connec i i y (Figu e 1F, yellow and pink do s, espec i ely). As examples, genomic egion 141 ep esen a ion o he Insulin Recep o Subs a e 1 (I s1) gene, which is equi ed o insulin signaling 142 and ela ed spine ma u a ion and synap ic plas ici y (25) and he Glycogen Syn hase Kinase 3 Be a 143 (Gsk3b) gene a e shown (Figu e 1G), wi h signi ican ace yla ion deple ion o bo h ma ks in he 144 ca eine- ea ed g oup e sus con ol ( espec i ely le , H3K9/14ac, FDR=7.75E-05 and H3K27ac, 145 FDR=1.82E-12; igh , H3K9/14ac, FDR=2.58E-11 and H3K27ac, FDR=4.83E-05). O he egions, 146 such as hose associa ed wi h Dusp3, Psme3 and Mlh3 genes, did no exhibi such his one 147 ace yla ion changes upon ca eine ea men , a es ing o selec i i y o he ca eine e ec o bo h 148 his one ma ks (Supplemen al Figu e 1C). In addi ion, in eg a ed pa hway analysis (IPA) applied o 149 7 common ChIP-seq da a o bo h ma ks con i med ha me abolic pa hways, such as insulin o IGF-1 150 signaling, we e canonical pa hways down egula ed upon ca eine ea men (Supplemen al Table 151 3). Po en ial con ibu o s o he ca eine e ec s on he epigenome we e u he assessed using he 152 “ups eam egula o analysis” unc ion o IPA (Supplemen al Table 4). We iden i ied in he 153 ace yla ion-deple ed genes, TCF7L2 (T ansc ip ion ac o 7-like 2) as he mos signi ican ups eam 154 egula o inhibi ed upon ca eine consump ion o bo h ma ks. Fu he mo e, ADORA2A (A2AR) was 155 iden i ied as ano he ups eam egula o in he epigenomic da a, in s iking acco dance wi h he 156 p ima y abili y o ca eine o an agonize adenosine ecep o s (20). Al oge he , hese da a show ha 157 in he bulk hippocampus, ch onic ca eine ea men induces an o e all deace yla ion o wo ac i e 158 ansc ip ion ma ks, H3K27ac and H3K9/14ac, on genes ela ed o ansla ion, lipid and 159 glucose/insulin- ela ed me abolisms. 160 To assess whe he his his one ace yla ion deple ion exe s an e ec on gene ansc ip ion, we 161 pe o med RNA-sequencing (RNA-seq) o bo h wa e and ca eine- ea ed mice. Al hough di e en ial 162 exp ession analysis e ealed no s a is ically signi ican changes o gene exp ession be ween g oups 163 (Supplemen al Figu e 2A), ela i e quan i ica ion o he gene exp ession (z-sco e) co esponding 164 o all H3K27ac-deple ed loci showed an o e all dec ease in exp ession (Supplemen al Figu e 2B) 165 o e he same numbe o andomly chosen genes. Fu he mo e, we also checked by RT-qPCR (n=5- 166 6/g oup) exp ession le els o se e al genes chosen amongs he mos deple ed ones in H3K27ac 167 and obse ed a dec eased exp ession ollowing ch onic ca eine ea men (Supplemen al Figu e 168 2D, ed columns). Impo an ly, we ound ha some o hese genes, such as PBX Homeobox 1 169 (Pbx1), NAD Kinase 2 (Nadk2) and Spindle And Cen iole Associa ed P o ein 1 (Spice1), displayed 170 dec eased exp ession no only upon ch onic (2 weeks) bu also ollowing an acu e (24h) ca eine 171 ea men (Supplemen al Figu e 2D, g een columns). Howe e , he Cy och ome P450 Family 51 172 Sub amily A Membe 1 (Cyp51) gene, ha plays a cen al ole in choles e ol and lipid me abolisms, 173 showed dec eased exp ession solely upon ch onic ca eine ea men . Mo eo e , a pe sis en e ec 174 o ca eine on gene exp ession was obse ed o Pbx1 and Nadk2 genes, as hei exp ession 175 8 emained dec eased e en a e a 2-week ca eine wi hd awal ollowing ch onic adminis a ion 176 (Supplemen al Figu e 2D, blue columns). 177 178 Impac o ch onic ca eine consump ion on hippocampal me abolome. Conside ing ha 179 ca eine dec eased his one ace yla ion o me abolic- ela ed genes, we u he assessed he impac 180 o he dec eased his one ace yla ion on he hippocampal me abolome. To do so, issue spa ial 181 dis ibu ion o molecules was isualized by MALDI (ma ix assis ed lase deso p ion ioniza ion) mass 182 spec ome y imaging analysis, acqui ed om he do sal hippocampus (B egma -1.7mm; Figu e 2A) 183 o wa e and ca eine- ea ed mice (n=6/g oup). PCA analysis was hen pe o med on he eco ded 184 mass spec ome y images om bo h mouse g oups (wa e and ca eine- ea ed), in o de o highligh 185 di e ences in hei hippocampal molecula dis ibu ion p o iles (Figu e 2B). This e ealed lipidomic 186 and me abolomic signa u es ela ed o ch onic ca eine in ake, esul ing in wo dis inc ly sepa a ed 187 clus e s. The iden i ica ion o me aboli es and lipids was based on he measu emen o hei m/z and 188 subsequen compa ison wi h di e en da abanks. In o al, 59% o he me abolome was assigned o 189 he biochemical class o me aboli es (27%) and lipids (32%) (Figu e 2C). The m/z alue o he 190 emaining 41% did no allow o a uni ocal assignmen o a speci ic biochemical class. Ul ima ely, 191 s a is ical analysis o he molecula da ase s e ealed ha ch onic ca eine consump ion induced a 192 majo dec ease in me aboli es and lipid le els (92% dec eased s. 8% inc eased; Figu e 2D). The 193 iden i ied species be ween wa e and ca eine g oups (p < 0.05), de ec ed in posi i e and nega i e 194 ioniza ion mode, a e lis ed in Supplemen al Table 5. Rela ed molecula images aken om 195 hippocampi o wa e and ca eine- ea ed mice, showing hei di e en le els and dis ibu ion a e 196 displayed in Figu e 2E. 197 198 P o eomic hippocampal signa u e associa ed wi h ch onic ca eine consump ion. To gain 199 insigh s in o he po en ial e ec o ch onic ca eine in ake a he p o ein le el, we pe o med mass 200 spec ome y p o eomic analysis o he bulk do sal hippocampus o wa e (con ol) and ch onic 201 9 ca eine- ea ed mice (n=3/g oup). Ca eine induced al e a ions o 179 p o eins, o which 49 202 displayed dec eased and 130 inc eased exp ession le els (Figu e 3A, Supplemen al Table 6). In 203 line wi h he wo p e ious da ase s (epigenomics and me abolomics), gene on ology and p o ein 204 ne wo k analysis e ealed ha dec eased p o eins we e again associa ed wi h pep ide and cellula 205 amide me abolic p ocesses as well as wi h mi ochond ia, wi h educ ion o NADH:Ubiquinone 206 Oxido educ ase Subuni A3 (NDUFA3) in ol ed in mi ochond ial espi a o y chain complex I 207 assembly, o Mi ochond ial Py u a e Ca ie 1 (MPC1) esponsible o anspo ing py u a e in o 208 mi ochond ia o o Long-Chain-Fa y-Acid-CoA Ligase 4 (ACSL4) in ol ed in lipid me abolism 209 (Figu e 3B). Toge he , hese h ee app oaches sugges a obus dec ease in me abolic p ocesses 210 induced by ch onic ca eine in ake in he bulk hippocampal issue. 35 ou o he 49 p o eins 211 dec eased by ca eine, including Insulin Deg ading Enzyme (IDE) and NDUFA3, we e e e sed by 212 ca eine wi hd awal. Only 14 p o eins, such as Insulin Like G ow h Fac o 2 Recep o (IGF2R) 213 emained dec eased ollowing ca eine wi hd awal (Supplemen al Table 6). 214 Gene On ology analysis o he inc eased p o eins e ealed h ee main p o ein clus e s: one ela ed 215 wi h RNA-binding and spliceosome, a second linked o au ophagosome and p o ein p ocessing o 216 endoplasmic e iculum, and a las one associa ed wi h glu ama e gic synapse and phospha ase 217 ac i i y. Conside ing ha ca eine induced exp ession o some synap ic p o eins, and con ols 218 glu ama e gic synap ic ansmission (e.g. (19), we u he assessed hei p edic ed ole in he 219 synap ic compa men using he Synap ic Gene On ologies and anno a ions (SynGO) (26). We 220 obse ed ha mos o he synap ic p o eins anno a ed we e ela ed o synap ic o ganiza ion and 221 signaling, mo e pa icula ly, o chemical synap ic ansmission, such as SH3 And Mul iple Anky in 222 Repea Domains 3 (SHANK3) ha encodes c i ical sca olding p o eins o glu ama e gic 223 neu o ansmission in he pos -synap ic densi ies (27), Synap opodin (SYNPO) a pa o he ac in 224 cy oskele on o pos synap ic densi ies (28) o CREB–Regula ed T ansc ip ion Coac i a o 1 225 (CRTC1) in ol ed in hippocampal plas ici y and memo y (29). O e all, p o eomic analysis e ealed 226 a dec ease in me abolism- ela ed p o eins, concomi an wi h an inc ease o neu onal/synapse- 227 16 in mi ochond ial ac i i y (e.g. NDUFA3 and MPC1). These ch onic changes we e o some poin 369 ela ed o acu e ca eine ea men as a ew genes we e simila ly impac ed ollowing a 24h and a 2- 370 week ca eine ea men , in line wi h Yu e al., 2009 (41), bu he main changes we e associa ed wi h 371 long- e m exposu e o ca eine, as ound o e.g. he Cyp51 gene, encoding a p o ein in ol ed in 372 choles e ol and lipid me abolism. In acco dance, we ound ha 14 o e 49 down egula ed 373 hippocampal p o eins we e s ill al e ed despi e 2 weeks o ca eine wi hd awal, indica ing a 374 pe sis ence o ch onic ca eine e ec s, as p e iously sugges ed (42). Among hese long-las ing 375 impac ed p o eins by ch onic ca eine in ake, we ound ACSL4 and GNA14, which a e in ol ed in 376 he cellula syn hesis o a y acids/lipids, o IGF2 ecep o and ITPR3, in ol ed in insulin-dependen 377 egula ions. Impo an ly, hese da a a e in line wi h and b ing molecula suppo o ecen unc ional 378 magne ic esonance imaging da a showing ha habi ual co ee d inke s exhibi dec eased b ain 379 unc ional connec i i y a es (43). As bulk hippocampal issue was in es iga ed, a ques ion lies in 380 unde s anding he cellula ypes unde lying such me abolic dec ease. Independen IPA analysis o 381 ou wo se s o epigenomic da a (ChIP-seq on bulk hippocampal issue and CUT&Tag-seq on 382 dissocia ed hippocampal cells, “all cells”) pa icula ly poin ed a h ee common ups eam egula o s: 383 TCF7L2 ( ansc ip ion ac o 7 like 2), MKNK1 (MAPK in e ac ing se ine/ h eonine kinase 1) and 384 NFASC (neu o ascin). In he mouse b ain, hese genes a e p edominan ly exp essed by non- 385 neu onal cells: TCF7L2 is p e e en ially exp essed by newly o med oligodend ocy es and 386 as ocy es, NFASC in newly o med oligodend ocy es, while MKNK1 is pa icula ly en iched in 387 mic oglia (see h ps://www.b ain naseq.o g/). IPA analysis o “all cells” CUT&Tag-seq da a u he 388 highligh ed he in ol emen o GLI1 and SOX2, ha a e bo h pa icula ly en iched in as ocy es. 389 These obse a ions s ongly suppo ha he basal/ es ing signa u es elici ed by ch onic ca eine 390 in ake may ely on non-neu onal, likely glial, esponses. 391 Concomi an wi h his de-ace yla ion p ocess obse ed in he bulk hippocampus, we showed ha 392 ch onic ca eine was able o induce a neu on-au onomous epigenomic esponse using bo h ac i e 393 (H3K27ac) and ep essi e (H3K27me3) ma ks: ace yla ion o H3K27 was en iched while i s i- 394 17 me hyla ion was deple ed a genes ela ed o memb ane po en ial, po assium ion egula ion and 395 lea ning and memo y p ocesses. This sugges s ha he o e all ch onic ca eine e ec posi i ely 396 egula es neu onal ac i i y and synap ic ansmission. P o eomic s udies suppo ed his a gumen as 397 a se ies o iden i ied up egula ed p o eins we e ela ed o he glu ama e gic synapse. I is in e es ing 398 o no e ha 73 ou o 130 up egula ed p o eins -some o hem ela ed o he synapse- emained 399 ele a ed e en a e a 2-weeks ca eine wi hd awal, e ealing a long-las ing impac o ch onic ca eine 400 in ake on neu ons. In eg a ion o epigenomic and p o eomic da a pa icula ly poin ed owa ds 401 CRTC1, known o ac as a coincidence senso o calcium and cAMP signals in neu ons igge ing a 402 ansc ip ional esponse in ol ed in la e-phase LTP main enance a hippocampal synapses (44). We 403 u he obse ed ha ch onic ca eine in ake impac s he lea ning/ aining-induced ansc ip ome by 404 signi ican ly enhancing he numbe o di e en ially egula ed genes. In eg a ion o he lea ning- 405 induced genes wi h epigenomic da a iden i ied a g oup o 121 genes ela ed o me abolic p ocesses 406 ha , besides being o e -ac i a ed in ca eine- ea ed mice in lea ning condi ions, we e also de- 407 ace yla ed wi h dec eased o e all exp ession in es ing condi ions (z-sco e). This sugges s ha he 408 es ing-s a e e ec o ca eine in non-neu onal/glial cells migh be a p e- equisi e o he obus 409 ac i a ion o me abolic pa hways hen imp o ing quali y and p ecision o lea ning-associa ed 410 p ocesses, in line wi h i s cogni i e enhancing unc ion. 411 Thus, a majo o e all conclusion o he p esen s udy is he abili y o egula ca eine in ake o exe 412 a long- e m e ec on neu onal ac i i y/plas ici y in he adul b ain, h ough conce ed ac ions on he 413 epigenome, ansc ip ome, p o eome and me abolome, ul ima ely lowe ing me abolic- ela ed 414 p ocesses; and o simul aneously inely uning ac i i y-dependen egula ions o a mo e e icien 415 esponse o expe ience. In o he wo ds, in non-neu onal cells ca eine dec eases -omic ac i i ies 416 unde basal condi ions and imp o es he signal- o-noise a io du ing in o ma ion encoding in b ain 417 ci cui s, hus con ibu ing o bols e he salience o in o ma ion in b ain ci cui s. Rema kably, his dual 418 and opposi e impac o ca eine unde es ing condi ions and upon b ain ac i a ion is in line wi h 419 human b ain imaging s udies: unde basal condi ions ca eine inc eased b ain en opy (45) and 420 18 dec eased unc ional connec i i y (46), whe eas i inc eases BOLD ac i a ion in he on opola and 421 cingula e co ex in a e bal wo king memo y ask (47) e lec ing an inc eased p ocessing po en ial. 422 Addi ionally, neu ophysiological s udies on he pu a i e a ge s o ca eine - adenosine ecep o s – 423 a e in line wi h his dual ole o ca eine, as shown by he opposi e e ec s o A2AR o enhance 424 glu ama e elease con as ing wi h he A1R-media ed inhibi ion o basal synap ic ansmission (48), 425 which is also con olled by A2AR (49). Finally, ou da a also show ha he ampli ude o he 426 ansc ip omic e ec s o ca eine was a g ea e when neu onal ne wo ks we e ac i a ed du ing he 427 lea ning p ocess a he han in basal condi ions, as no ed by o he s when s udying he impac o 428 ca eine on gene exp ession in he basal ganglia (50). This migh pa icula ly ela e o a “p iming” o 429 neu onal ac i i y which would a o he ise o ac i i y-dependen esponse, as i has been sugges ed 430 o he mechanism o ac ion o HDAC inhibi o s (51). How ca eine coo dina es hese epigenomic 431 esponses in he di e en cell ypes is an in e es ing ques ion ha we a e cu en ly pu suing. 432 Finally, he p esen s udy highligh s he molecula impac o ca eine in he homeos a ic b ain, ha 433 will dese e u he in es iga ions, namely ega ding he di e en ial mechanisms ope a ing a he 434 cell-speci ic le el o modula e physiological b ain ac i i y in es ing and ac i i y se ings. Ou da a 435 ha e addi ional a - eaching implica ions. While i is ecognized ha ca eine exhibi s no malizing 436 p ope ies in models o synap ic dys unc ion, as in Alzheime ’s disease (52–54), he cell-speci ic 437 molecula mechanisms emains o be unco e ed. In he opposi e side o he allos a ic b ain spec um 438 (55), ca eine has been sugges ed o impac synap ic a e in b ain de elopmen (56, 57) bu he 439 in ol emen o neu onal s. non-neu onal mechanisms emains ill-de ined. I is he e o e pa icula ly 440 ele an and impo an o add ess, a a la ge scale, he in eg a ed ac ions o ca eine in neu onal s. 441 non-neu onal cells in he imma u e, homeos a ic and ageing b ain. 442 443 19 Ma e ials and Me hods 444 445 Animals. Male C57Bl6/J mice (Cha les Ri e Labo a o ies, F ance) we e housed in a pa hogen- ee 446 acili y (Uni e si y o Lille, F ance). Mice we e 5-6 pe cage (GM500, Tecniplas ) and main ained 447 unde con olled housing condi ions o empe a u e (22°C) and ligh (12-hou ligh /da k cycle), wi h 448 ad libi um access o ood and wa e . 449 450 Ca eine ea men . Two- h ee-mon hs-old mice we e andomly assigned o he wo ollowing 451 expe imen al g oups: wa e (con ol) and ca eine. Ca eine solu ions we e kep in da k bo les hus 452 p o ec ed om ligh and changed weekly. T ea men s a ed a 8-9 weeks o age and las ed o wo 453 weeks. The ch onic ca eine ea men in mice has been se in o de o mimic he usual dose ange 454 o ca eine consump ion in Humans. The selec ed ca eine dose o 0.3 g/L p.o., adminis e ed h ough 455 d inking wa e a 0.3 g/L, has been p e iously shown o p o ide a signi ican bene i in 456 neu odegene a i e con ex s (54, 58, 59). Rega ding he compa ison o ca eine exposu e o 2 457 weeks s. 24 hou s s. ca eine emo al, we p oceed as ollows: 6 animals we e kep unde wa e 458 and o he 6 animals we e ea ed wi h ca eine o 2 weeks and e u ned o wa e o 2 addi ional 459 weeks (ca eine wi hd awal g oup). When he la e g oup o animals e u ned o wa e , an addi ional 460 g oup ha was unde wa e o 2 weeks was hen ea ed wi h ca eine. A las g oup was kep unde 461 wa e o 2 weeks and ea ed wi h ca eine o only 24 hou s. All animals we e hen sac i iced he 462 same day, he do sal hippocampus was sampled and s o ed as indica ed below and used o 463 p o eomics and RT-qPCR analysis. 464 465 Quan i a i e de e mina ion o ca eine and me aboli es in b ain samples. B ain issues om 466 wa e and ca eine g oups we e used o assess concen a ions o ca eine and i s me aboli es 467 (pa axan hine, heob omine and heophylline). Samples we e weighed and 1 mL o 1% o mic acid 468 (FA) solu ion was added o each sample. To de e mine he eco e y a e, con ol samples we e 469 20 spiked wi h a mix u e o ca eine, pa axan hine, heob omine and heophylline (10 µM each). The 470 issues we e lysed using 7 mm s ainless s eel beads and Tissue Lyse LT (Qiagen) o 8 min a 50 471 s okes/minu e, hen ea ed wi h an ul asonic ba h o 5 minu es and subsequen ly cen i uged o 472 15 minu es a 23000xg and 4°C. The supe na an s we e ans e ed o Amicon® Ul a 2 ml 3K 473 cen i ugal il e uni s (Me ck). The emaining pelle s we e subjec ed o he same p o ocol o issue 474 dis up ion and cen i uga ion using 1 mL o acidi ied wa e (FA 1%). Amicon® il e s con aining he 475 combined supe na an s om he wo- old ex ac ion p ocess we e cen i uged o 140 minu es a 476 7500xg and 23°C. Fil a es we e used o liquid ch oma og aphy-mass spec ome y analysis. 477 Samples we e sepa a ed by using a Dionex Ul iMa e 3000 HPLC sys em wi h an in eg a ed a iable 478 wa eleng h de ec o , se a 280 nm, and equipped wi h a C18 column (EC Nucleodu ® C18 G a i y 479 column, 2 mm ID x 50 mm, 3 µm, Mache ey & Nagel). Samples (5 µL) we e injec ed a low a e o 480 300 µL/minu es. A sol en g adien was un om 90% A (wa e con aining 0.2% FA and 2 mM 481 ammonium ace a e) and 10% B (me hanol con aining 2 mM ammonium ace a e) o 50% A and 50% 482 B o e 10 minu es. 483 The elua e was analyzed wi h a coupled mass spec ome e ESI-mic OTOF-Q (B uke Dal onics). 484 Da a we e acqui ed in posi i e ull scan MS mode wi h a scan ange m/z 50-1000. Iden i ica ion and 485 quan i ica ion o he xan hine de i a i es we e pe o med using Da a Analysis so wa e (B uke 486 Dal onics). The limi o de ec ion was 5 nM o ca eine and 10 nM o i s me aboli es (pa axan hine, 487 heob omine and heophylline). 488 489 Lea ning ac i a ion in he Mo is wa e maze. An A lan is Mo is Wa e Maze (MWM) ank was 490 placed in a oom wi h se e al isual ex a-maze cues. Wa e opaci ied wi h powde ed chalk (Blanc 491 de meudon) was main ained a a empe a u e o 21°C. Mice om wa e (con ol) and ca eine g oups 492 we e habi ua ed o he se -up o wo consecu i e days (habi ua ion 1 and 2). Du ing habi ua ion 1, 493 mice we e allowed o disco e he pool illed wi h 5 cm heigh o wa e and a isible pla o m du ing 494 60 seconds. Du ing habi ua ion 2, mice we e allowed o swim in he pool illed wi h wa e in absence 495 21 o he pla o m o 60 seconds. The ollowing 3 days (acquisi ion day 1–3), mice we e ained o 496 localize he pla o m hidden unde nea h he opaci ied wa e using he spa ial cues p esen in he 497 oom. In each acquisi ion day, mice pe o med ou ials each o 60 seconds maximal du a ion. Each 498 ial was e mina ed when he mouse eached he pla o m o a e he 60 seconds. Mice ailing o 499 ind he pla o m we e gen ly guided o he pla o m and allowed o s ay o 8–10 seconds. Du ing he 500 aining days, mice we e subjec ed o MWM in a andom o de , so ha hey we e es ed a di e en 501 imes o he day. All MWM e alua ions o ca eine- o wa e - ea ed mice we e pe o med by 502 expe imen e blind o mouse ea men s. 503 504 Sac i ice and b ain issue p epa a ion. Fo ansc ip omic analysis, mice om Lea ning g oup we e 505 killed by ce ical disloca ion, one hou a e he las aining sec ion, while mice om he Home cage 506 g oup we e killed a he same ime. F eshly dissec ed issues we e immedia ely ozen in liquid 507 ni ogen and kep a -80°C un il RNA ex ac ion. Simila sac i ice p ocedu es we e used o animals 508 used o p o eomic and RTqPCR analyses. Fo molecula MALDI imaging expe imen s, mice we e 509 deeply anes he ized wi h sodium pen oba bi al (50 mg/kg, i.p.), and hen ansca dially pe used wi h 510 cold NaCl (0.9%). B ains we e collec ed, ozen on d y ice and s o ed a -80°C un il use. 511 512 RNA-seq analysis. To al RNA was ex ac ed om do sal hippocampal issues using TRIzol eagen 513 (In i ogen) (n=4/g oup). F eshly dissec ed issue was chopped, homogenized in 300 μL o TRIzol 514 eagen , and ozen (20 minu es a -80°C), ollowed by 3-minu es cen i uga ion a 14000xg be o e 515 chlo o o m/isoamyl ex ac ion. The supe na an was used o p ecipi a e RNA wi h isop opanol and 516 RNase- ee glycogen (30 minu es a 4°C). The pelle was washed once wi h 70% e hanol and 517 esuspended in Milli-Q wa e . A new RNA p ecipi a ion was pe o med wi h 100% e hanol and 3 M 518 sodium ace a e (o e nigh a -20°C). A e wo u he 70% e hanol washes, he pelle was ai -d ied 519 and esuspended in 30 μL nuclease- ee Milli-Q wa e , hea ed 6 minu es a 50°C, and RNA 520 quan i ica ion was pe o med. RNA-seq lib a ies (n=4/g oup) we e gene a ed om 500 ng o o al 521 22 RNA using Illumina® T uSeq® S anded mRNA Lib a y P ep Ki 2. B ie ly, ollowing pu i ica ion wi h 522 poly-T oligo a ached magne ic beads, he mRNA was agmen ed using di alen ca ions a 94°C o 523 2 minu es. The clea ed RNA agmen s we e copied in o i s -s and cDNA using e e se 524 ansc ip ase and andom p ime s. S and speci ici y was achie ed by eplacing dTTP wi h dUTP 525 du ing he second-s and cDNA syn hesis by DNA Polyme ase I and RNase H. Following he addi ion 526 o a single “A” base and he subsequen liga ion o he adap e on double-s anded cDNA agmen s, 527 he p oduc s we e pu i ied and en iched wi h PCR [30 s a 98°C; (10 seconds a 98°C, 30 seconds 528 a 60°C, 30 seconds a 72°C) × 12 cycles; 5 minu es a 72°C] o c ea e he cDNA lib a y. Su plus 529 PCR p ime s we e u he emo ed by pu i ica ion using AMPu e XP beads (Beckman Coul e ), and 530 he inal cDNA lib a ies we e checked o quali y and quan i ied using capilla y elec opho esis. 531 Sequencing was pe o med on he Illumina® Genome Hiseq4000 as single-end 50 base eads 532 ollowing Illumina’s ins uc ions. Reads we e mapped on o he mm10 assembly o Mus musculus 533 genome using STAR 2.5.3a (60) and he Bow ie 2 aligne 2.2.8 (61). Only uniquely aligned eads 534 we e kep o u he analyses. Quan i ica ion o gene exp ession was pe o med using HTSeq-coun 535 0.6.1p1 (62) and gene anno a ions om Ensembl elease 90 and “union” mode. Read coun s we e 536 no malized ac oss lib a ies wi h he me hod p oposed by Ande e al. (2010) (63). Compa isons o 537 in e es we e pe o med using he es o di e en ial exp ession p oposed by Lo e (64) and 538 implemen ed in he DESeq2 Bioconduc o lib a y ( 1.16.1). Resul ing p- alues we e adjus ed o 539 mul iple es ing using he Benjamini and Hochbe g me hod (65). 540 541 Ch oma in Immunop ecipi a ion (ChIP). F eshly dissec ed issue was chopped by a azo blade 542 and apidly incuba ed in 1.5 mL phospha e-bu e ed saline (PBS) con aining 1% o maldehyde o 543 10 minu es a oom empe a u e. To s op ixa ion, glycine was added (0.125 M inal concen a ion). 544 Do sal hippocampi om 4 mice we e pooled pe sample and wo biological eplica es pe condi ion 545 we e used o he ChIP-seq. Tissue samples we e hen p ocessed as desc ibed in Cha e jee e al. 546 (34) and sonica ed using he Diagenode Bio up o (30 seconds ON-30 seconds OFF a High Powe 547 23 x 35 cycles). Sonica ed ch oma in was cen i uged 10 minu es a 14000xg, he supe na an collec ed 548 and dilu ed 1:10 in ChIP dilu ion bu e (0.01% SDS, 1.1% T i on X-100, 1.2 mM EDTA, 16.7 mM 549 T is-Cl, pH 8.1, 167 mM NaCl). A ac ion o he supe na an (50 µL – 10%) om each sample was 550 sa ed be o e immune-p ecipi a ion o ‘ o al inpu ch oma in’. Supe na an s we e incuba ed o e nigh 551 (4°C) wi h 1/1000 p ima y an ibodies agains H3K9/14ac (Diagenode #C15410200) and H3K27ac 552 (Abcam #ab4729), ollowed by p o ein A Dynabeads (In i ogen) o 2 hou s a oom empe a u e. 553 A e se e al washes (low sal , high sal , LiCl and TE bu e s), he esul ing DNA-p o ein complexes 554 we e elu ed in 300 µL elu ion bu e (1% SDS, 0.1 M NaHCO3). The c osslinking was e e sed 555 (o e nigh a 65°C) and he DNA was subsequen ly pu i ied wi h RNAse (30 minu es a 37°C) and 556 p o einase K (2 hou s a 45°C). DNA om he immunop ecipi a ed and inpu samples was isola ed 557 using Diagenode Mic oChIP DiaPu e columns wi h 20 µL nuclease- ee milliQ wa e in low binding 558 ubes. ChIP samples we e u he pu i ied a he Genomeas Pla o m using Agencou AMPu e XP 559 beads (Beckman Coul e ) and quan i ied using Qubi (In i ogen). 560 561 ChIP-seq lib a ies and sequencing. ChIP-seq lib a ies we e p epa ed om 2-10 ng o double- 562 s anded pu i ied DNA using he Mic oPlex Lib a y P epa a ion ki 2 (C05010014, Diagenode s.a., 563 Se aing, Belgium), acco ding o manu ac u e 's ins uc ions. DNA was i s epai ed and yielded 564 molecules wi h blun ends. Nex , s em-loop adap o s wi h blocked 5’ ends we e liga ed o he 5’ end 565 o he genomic DNA (gDNA), lea ing a nick a he 3’ end. The adap o s canno liga e o each o he 566 and do no ha e single-s and ails hus non-speci ic backg ound is a oided. In he inal s ep, he 3’ 567 ends o he gDNA we e ex ended o comple e lib a y syn hesis and Illumina compa ible indexes we e 568 added h ough a PCR ampli ica ion (4+7 cycles). Ampli ied lib a ies we e pu i ied and size-selec ed 569 using Agencou AMPu e XP beads (Beckman Coul e ) o emo e uninco po a ed p ime s and o he 570 eagen s. P io o analyses, DNA lib a ies we e checked o quali y and quan i ied using a 2100 571 Bioanalyze (Agilen ). The lib a ies we e loaded in he lowcell a 8 pM concen a ion, and clus e s 572 24 we e gene a ed using he Cbo and sequenced using he Illumina HiSeq 4000 echnology as single- 573 end 50 base eads ollowing Illumina’s ins uc ions. Image analysis and base calling we e pe o med 574 using RTA and CASAVA. 575 576 ChIP-seq analyses. Sequenced eads we e mapped o he Mus musculus genome assembly mm10 577 using Bow ie 1.0.0 wi h he ollowing pa ame e s «-m1-s a a-bes -y-l40». Sam ools me ge 1.3.1 578 (66) was used o combine biological eplica es by condi ion. Then, BED ools in e sec 2.26.0 (67) 579 was used o emo e eads loca ed wi hin ENCODE blacklis ed egions. SICER (SICER-d .sh) 1.1 580 (68) was used o de ec di e en ially bound egions on he pools o biological eplica es using he 581 ollowing pa ame e s: «Species: mm10, E ec i e genome size as a ac ion o e e ence genome: 582 0.74, Th eshold o edundancy allowed o ea ed eads: 1, Th eshold o edundancy allowed o 583 WT eads: 1, Window size: 200 bps, F agmen size: 200 bps, Gap size: 600 bps, FDR o 584 iden i ica ion o en iched islands: 1E-2, FDR o iden i ica ion o signi ican changes: 1E-2. Finally, 585 di e en ially bound egions we e anno a ed wi h espec o he closes gene using Home 586 anno a ePeaks.pl 4.11.1 (69). An FDR o 1E-5 was used in di e en ial analyses (ca eine s. 587 con ol). 588 589 Neu onal and all cells isola ion. Neu onal and all cells suspensions we e ob ained om mouse 590 hippocampus ch onically ea ed wi h ca eine o wa e (con ol). Fo ha , we used Neu al Tissue 591 Dissocia ion (Mil enyi, #130-092-628) and Neu on Isola ion Ki s (Mil enyi, #130-115-389), ollowing 592 manu ac u e 's ins uc ions wi h some adap a ions. B ie ly, wo mouse hippocampi we e pooled pe 593 sample and ha es ed in a p e-hea ed bu e solu ion con aining papain. This was ollowed by se ies 594 o manual mechanical dissocia ions, using scisso s and i e polished Pas eu pipe es o descending 595 diame e , and incuba ions a 37°C unde slow o a ion. The solu ion was hen il e ed (50 µm) and 596 cen i uged (10 minu es, 300xg, a oom empe a u e) and myelin was emo ed using Myelin 597 Remo al Beads II ki (Mil enyi, #130-096-733), incuba ing o 15 minu es a 4°C, cen i uging (10 598 25 minu es, 300xg a 4°C) and il e ing he sample h ough MS columns (Mil enyi, #130-042-201) placed 599 in MiniMACS™ Sepa a o (Mil enyi, #130-042-102) o collec he myelin deple ed low- h ough, ee 600 o cell deb is. The ‘all cells’ suspension was collec ed a his poin and coun ed using he TC20 601 Au oma ed Cell Coun e (Bio-Rad, #1450102) o ob ain a o al o 70,000 cells pe sample. Wi h he 602 emaining o he samples, we p oceeded wi h neu onal isola ion acco ding o manu ac u e 's 603 ins uc ions, inally deple ing he samples h ough MS columns o collec he low- h ough en iched 604 in neu ons. The samples we e coun ed and 70,000 cells pe sample we e aken o CUT&Tag 605 expe imen s. 606 607 Clea age Unde Ta ge s and Tagmen a ion (CUT&Tag). Ha ing isola ed all cells and neu onal 608 popula ions we p oceeded wi h CUT&Tag me hod o assess hei genome-wide H3K27ac and 609 H3K27me3 ch oma in s a e. The p o ocol was adap ed om ha desc ibed by Kaya-Oku e al., 2019 610 (31) The me hod is based on digi onin-induced cell pe meabiliza ion (Sigma, #300410-250MG) and 611 concana alin A-coa ed magne ic beads (Cell signaling, #93569S) immobiliza ion. This is ollowed by 612 o e -nigh incuba ion a 4°C wi h p ima y an ibodies agains H3K27ac (Abcam, #ab4729) and 613 H3K27me3 (Diagenode, #C15410195), ollowed by 1 hou incuba ion wi h he seconda y an ibody 614 (An ibodies online, #ABIN101961). The loaded-Tn5 is hen added (Diagenode, #C01070001) and 615 he clea ed DNA is ex ac ed using MinElu e PCR Pu i ica ion Ki (Quiagen, # 28004). Lib a y 616 p epa a ion was conduc ed using Nex e a p ime s (Illumina, #FC-131-2001) and pos -PCR clean-up 617 using SPRI bead slu y (Beckmann Coul e , #B23317). Concen a ion o he collec ed DNA was 618 achie ed by Qubi (In i ogen, #Q32851). Two biological eplica es we e used pe g oup and Rabbi 619 IgG (Diagenode #C15410206) was used as con ol. 620 621 CUT&Tag analyses. Reads (pai ed-end) we e mapped o Mus musculus genome (assembly mm10) 622 using Bow ie2 (61) 2.2.8 wi h de aul pa ame e s excep o “–end- o-end- e y-sensi i e-no-mixed 623 –no-disco dan -I10-X700”. P io o peak calling, eads wi h mapping quali y below 30 we e emo ed 624 32 Re e ences 763 764 1. Smi h A. E ec s o ca eine on human beha io .. Food Chem Toxicol. 2002;40(9):1243–1255. 765 2. Kim Y, Je Y, Gio annucci E. Co ee consump ion and all-cause and cause-speci ic mo ali y: a 766 me a-analysis by po en ial modi ie s.. Eu J Epidemiol. 2019;34(8):731–752. 767 3. Lo ield E e al. Associa ion o Co ee D inking Wi h Mo ali y by Gene ic Va ia ion in Ca eine 768 Me abolism: Findings F om he UK Biobank. JAMA In e n Med. 2018;178(8):1086–1097. 769 4. F eedman ND, Pa k Y, Abne CC, Hollenbeck AR, Sinha R. Associa ion o co ee d inking wi h 770 o al and cause-speci ic mo ali y. N Engl J Med. 2012;366(20):1891–1904. 771 5. Fla en V e al. F om epidemiology o pa hophysiology: wha abou ca eine in Alzheime ’s disease? 772 Biochem Soc T ans. 2014;42(2):587–592. 773 6. Cunha RA. How does adenosine con ol neu onal dys unc ion and neu odegene a ion?. J 774 Neu ochem. 2016;139(6):1019–1055. 775 7. Cellai L e al. The Adenosine gic Signaling: A Complex bu P omising The apeu ic Ta ge o 776 Alzheime ’s Disease. F on Neu osci. 2018;12:520. 777 8. W igh GA e al. Ca eine in Flo al Nec a Enhances a Pollina o 's Memo y o Rewa d. Science. 778 2013;339(6124):1202– 1204. 779 9. Ma ques S, Ba alha VL, Lopes LV, Ou ei o TF. Modula ing Alzheime ’s disease h ough ca eine: 780 a pu a i e link o epigene ics.. J Alzheime s Dis. 2011;24 Suppl 2:161–171. 781 10. Angelucci MEM, Cesá io C, Hi oi RH, Rosalen PL, Da Cunha C. E ec s o ca eine on lea ning 782 and memo y in a s es ed in he Mo is wa e maze. B azilian J Med Biol Res. 2002;35(10):1201– 783 1208. 784 11. Bo o a D e al. Pos -s udy ca eine adminis a ion enhances memo y consolida ion in humans. 785 Na Neu osci. 2014;17(2):201–203. 786 12. Lopes JP, Pliásso a A, Cunha RA. The physiological e ec s o ca eine on synap ic ansmission 787 and plas ici y in he mouse hippocampus selec i ely depend on adenosine A(1) and A(2A) ecep o s. 788 Biochem Pha macol. 2019;166:313–321. 789 13. Cos enla AR, Cunha RA, de Mendonça A. Ca eine, adenosine ecep o s, and synap ic plas ici y. 790 J Alzheime s Dis. 2010;20 Suppl 1:S25-34. 791 14. Simons SB, Ca uana DA, Zhao M, Dudek SM. Ca eine-induced synap ic po en ia ion in 792 hippocampal CA2 neu ons. Na Neu osci. 2011;15(1):23–25. 793 15. Lao-Pe eg ín C e al. Ca eine-media ed BDNF elease egula es long- e m synap ic plas ici y 794 h ough ac i a ion o IRS2 signaling. Addic Biol. 2017;22(6):1706–1718. 795 33 16. Blaise JH, Pa k JE, Bellas NJ, Gi chell TM, Phan V. Ca eine consump ion dis up s hippocampal 796 long- e m po en ia ion in eely beha ing a s. Physiol Rep. 2018;6(5):e13632. 797 17. Wa anabe Y, Ikegaya Y. Ca eine Inc eases Hippocampal Sha p Wa es in Vi o. Biol Pha m Bull. 798 2017;40(7):1111–1115. 799 18. Hanajima R e al. E ec o ca eine on long- e m po en ia ion-like e ec s induced by quad ipulse 800 ansc anial magne ic s imula ion. Exp B ain Res. 2019;237(3):647–651. 801 19. Ke kho s A e al. Ca eine Con ols Glu ama e gic Synap ic T ansmission and Py amidal Neu on 802 Exci abili y in Human Neoco ex. F on Pha macol. 2017;8:899. 803 20. F edholm BB, Bä ig K, Holmén J, Nehlig A, Z a au EE. Ac ions o ca eine in he b ain wi h 804 special e e ence o ac o s ha con ibu e o i s widesp ead use. Pha macol Re . 1999;51(1):83– 805 133. 806 21. Hein zman ND e al. Dis inc and p edic i e ch oma in signa u es o ansc ip ional p omo e s and 807 enhance s in he human genome. Na Gene . 2007;39(3):311–318. 808 22. Hnisz D e al. Supe -enhance s in he con ol o cell iden i y and disease. Cell 2013;155(4):934– 809 947. 810 23. J. PSC e al. Ch oma in s e ch enhance s a es d i e cell-speci ic gene egula ion and ha bo 811 human disease isk a ian s. P oc Na l Acad Sci. 2013;110(44):17921–17926. 812 24. Ka modiya K, K ebs AR, Oulad-Abdelghani M, Kimu a H, To a L. H3K9 and H3K14 ace yla ion 813 co-occu a many gene egula o y elemen s, while H3K14ac ma ks a subse o inac i e inducible 814 p omo e s in mouse emb yonic s em cells. BMC Genomics 2012;13:424. 815 25. Sánchez-Sa asúa S e al. IRS1 exp ession in hippocampus is age-dependen and is equi ed o 816 ma u e spine main enance and neu i ogenesis. Mol Cell Neu osci. 2022;118:103693. 817 26. Koopmans F e al. SynGO: An E idence-Based, Expe -Cu a ed Knowledge Base o he 818 Synapse. Neu on 2019;103(2):217-234.e4. 819 27. Sheng M, Kim E. The Shank amily o sca old p o eins. J Cell Sci. 2000;113(11):1851–1856. 820 28. Mundel P e al. Synap opodin: an ac in-associa ed p o ein in elencephalic dend i es and enal 821 podocy es. J Cell Biol. 1997;139(1):193–204. 822 29. Pa a-Damas A e al. CRTC1 Func ion Du ing Memo y Encoding Is Dis up ed in 823 Neu odegene a ion. Biol Psychia y 2017;81(2):111–123. 824 30. Wang L, Wal e P. Msp1/ATAD1 in P o ein Quali y Con ol and Regula ion o Synap ic Ac i i ies. 825 Annu. Re . Cell De Biol. 2020;36(1):141–164. 826 31. Kaya-Oku HS e al. CUT&Tag o e icien epigenomic p o iling o small samples and single cells. 827 Na Commun. 2019;10(1):1930. 828 32. Han S e al. Regula ion o dend i ic spines, spa ial memo y, and emb yonic de elopmen by he 829 34 TANC amily o PSD-95-in e ac ing p o eins. J Neu osci. 2010;30(45):15102–15112. 830 33. Pa a-Damas A, Rubió-Fe a ons L, Shen J, Sau a CA. CRTC1 media es p e e en ial 831 ansc ip ion a neu onal ac i i y- egula ed CRE/TATA p omo e s. Sci Rep. 2017;7(1):18004. 832 34. Cha e jee S e al. Reins a ing plas ici y and memo y in a auopa hy mouse model wi h an 833 ace yl ans e ase ac i a o . EMBO Mol Med. 2018;10(11). 834 35. Ma ínez G e al. Regula ion o Memo y Fo ma ion by he T ansc ip ion Fac o XBP1. Cell Rep. 835 2016;14(6):1382–1394. 836 36. Cao L e al. VEGF links hippocampal ac i i y wi h neu ogenesis, lea ning and memo y. Na 837 Gene . 2004;36(8):827–835. 838 37. Mews P e al. Ace yl-CoA syn he ase egula es his one ace yla ion and hippocampal memo y. 839 Na u e 2017;546(7658):381–386. 840 38. Jacobson KA, on Lubi z DK, Daly JW, F edholm BB. Adenosine ecep o ligands: di e ences 841 wi h acu e e sus ch onic ea men . T ends Pha macol Sci. 1996;17(3):108–113. 842 39. Fe é S. An upda e on he mechanisms o he psychos imulan e ec s o ca eine. J Neu ochem. 843 2008;105(4):1067–1079. 844 40. Doepke C e al. Ca eine: F iend o Foe? Annu Re Food Sci Technol. 2016;7:117–137. 845 41. Yu L e al. Unco e ing mul iple molecula a ge s o ca eine using a d ug a ge alida ion 846 s a egy combining A2A ecep o knockou mice wi h mic oa ay p o iling. Physiol Genomics 847 2009;37(3):199–210. 848 42. S enningsson P, Nomikos GG, F edholm BB. The s imula o y ac ion and he de elopmen o 849 ole ance o ca eine is associa ed wi h al e a ions in gene exp ession in speci ic b ain egions. J 850 Neu osci. 1999;19(10):4011–4022. 851 43. Magalhães R e al. Habi ual co ee d inke s display a dis inc pa e n o b ain unc ional 852 connec i i y. Mol Psychia y 2021;26(11):6589–6598. 853 44. A. KK e al. TORC1 is a calcium- and cAMP-sensi i e coincidence de ec o in ol ed in 854 hippocampal long- e m synap ic plas ici y. P oc Na l Acad Sci. 2007;104(11):4700–4705. 855 45. Chang D e al. Ca eine Caused a Widesp ead Inc ease o Res ing B ain En opy. Sci Rep. 856 2018;8(1):2700. 857 46. Tal O e al. Ca eine-Induced Global Reduc ions in Res ing-S a e BOLD Connec i i y Re lec 858 Widesp ead Dec eases in MEG Connec i i y. F on Hum Neu osci. 2013;7:63. 859 47. Koppels ae e F e al. Does ca eine modula e e bal wo king memo y p ocesses? An MRI 860 s udy. Neu oimage 2008;39(1):492–499. 861 48. Cunha RA. Di e en cellula sou ces and di e en oles o adenosine: A1 ecep o -media ed 862 inhibi ion h ough as ocy ic-d i en olume ansmission and synapse- es ic ed A2A ecep o - 863 35 media ed acili a ion o plas ici y. Neu ochem In . 2008;52(1–2):65–72. 864 49. Lopes L V, Cunha RA, Ribei o JA. C oss alk be ween A(1) and A(2A) adenosine ecep o s in 865 he hippocampus and co ex o young adul and old a s. J Neu ophysiol. 1999;82(6):3196–3203. 866 50. Dassesse D, Leden C, Pa men ie M, Schi mann SN. Acu e and ch onic ca eine adminis a ion 867 di e en ially al e s s ia al gene exp ession in wild- ype and adenosine A(2A) ecep o -de icien 868 mice. Synapse 2001;42(2):63–76. 869 51. Bu ns AM, G ä J. Cogni i e epigene ic p iming: le e aging his one ace yla ion o memo y 870 amelio a ion. Cu Opin. Neu obiol. 2021;67:75–84. 871 52. Dua e JMN, Cunha RA, Ca alho RA. Adenosine A₁ ecep o s con ol he me abolic eco e y 872 a e hypoxia in a hippocampal slices. J Neu ochem. 2016;136(5):947–957. 873 53. Lau en C e al. Bene icial e ec s o ca eine in a ansgenic model o Alzheime ’s disease-like 874 au pa hology. Neu obiol Aging 2014;35(9):2079–2090. 875 54. A endash GW e al. Ca eine p o ec s Alzheime ’s mice agains cogni i e impai men and educes 876 b ain be a-amyloid p oduc ion. Neu oscience 2006;142(4):941–952. 877 55. Da id B, V. LL. S abilizing synapses. Science. 2021;374(6568):684–685. 878 56. G. SC e al. Adenosine Recep o An agonis s Including Ca eine Al e Fe al B ain De elopmen 879 in Mice. Sci T ansl Med. 2013;5(197):197 a104-197 a104. 880 57. Fe an G-C e al. Con e gence o adenosine and GABA signaling o synapse s abiliza ion du ing 881 de elopmen . Science. 2022;374(6568):eabk2055. 882 58. A endash GW e al. Ca eine e e ses cogni i e impai men and dec eases b ain amyloid-be a 883 le els in aged Alzheime ’s disease mice. J Alzheime s Dis. 2009;17(3):661–680. 884 59. Lau en C e al. Bene icial e ec s o ca eine in a ansgenic model o Alzheime ’s disease-like 885 au pa hology. Neu obiol Aging 2014;35(9):2079–2090. 886 60. Dobin A e al. STAR: ul a as uni e sal RNA-seq aligne . Bioin o ma ics 2013;29(1):15–21. 887 61. Langmead B, Salzbe g SL. Fas gapped- ead alignmen wi h Bow ie 2. Na Me hods 888 2012;9(4):357–359. 889 62. Ande s S, Pyl PT, Hube W. HTSeq--a Py hon amewo k o wo k wi h high- h oughpu 890 sequencing da a. Bioin o ma ics 2015;31(2):166–169. 891 63. Ande s S, Hube W. Di e en ial exp ession analysis o sequence coun da a. Genome Biol. 892 2010;11(10):R106. 893 64. Lo e MI, Hube W, Ande s S. Mode a ed es ima ion o old change and dispe sion o RNA-seq 894 da a wi h DESeq2. Genome Biol. 2014;15(12):550. 895 65. Benjamini Y, Hochbe g Y. Con olling he False Disco e y Ra e - a P ac ical and Powe ul 896 App oach o Mul iple Tes ing. J R S a Soc Se B-Me hodological. 1995;57(1):289–300. 897 36 66. Li H e al. The Sequence Alignmen /Map o ma and SAM ools. Bioin o ma ics 898 2009;25(16):2078–2079. 899 67. Quinlan AR, Hall IM. BEDTools: a lexible sui e o u ili ies o compa ing genomic ea u es. 900 Bioin o ma ics 2010;26(6):841–842. 901 68. Xu S, G ullon S, Ge K, Peng W. Spa ial clus e ing o iden i ica ion o ChIP-en iched egions 902 (SICER) o map egions o his one me hyla ion pa e ns in emb yonic s em cells. Me hods Mol Biol. 903 2014;1150:97–111. 904 69. Zang C e al. A clus e ing app oach o iden i ica ion o en iched domains om his one 905 modi ica ion ChIP-Seq da a. Bioin o ma ics 2009;25(15):1952–1958. 906 70. Amemiya HM, Kundaje A, Boyle AP. The ENCODE Blacklis : Iden i ica ion o P oblema ic 907 Regions o he Genome. Sci Rep. 2019;9(1):9354. 908 71. Heinz S e al. Simple combina ions o lineage-de e mining ansc ip ion ac o s p ime cis- 909 egula o y elemen s equi ed o mac ophage and B cell iden i ies. Mol Cell 2010;38(4):576–589. 910 911 37 912 38 Figu e 1. Hippocampal epigenomic al e a ions associa ed wi h ch onic ca eine consump ion. 913 (A) Volcano plo showing he di e en ial en iched genomic egions o H3K9/14ac (ChIP-seq) upon 914 ch onic ca eine ea men (778 dec eased and 3 inc eased peaks). Red do s ep esen he 915 signi ican di e en egions (FDR<1E-5). (B) Genomic Regions En ichmen o Anno a ions Tool 916 (GREAT) analysis showing he mos en iched biological p ocesses associa ed wi h he H3K9/14ac 917 dec eased peaks in ca eine- ea ed mice. Blue a ows poin owa ds me abolic p ocesses and 918 ansla ion ela ed e ms. (C) Volcano plo ep esen ing he di e en ially egula ed egions o 919 H3K27ac upon ch onic ca eine ea men (2105 dec eased and 4 inc eased peaks, wi h FDR<1E- 920 5). (D) GREAT analysis ep esen ing he mos common biological p ocesses associa ed wi h he 921 H3K27ac dec eased peaks in he ca eine g oup. Regula ion o me abolic p ocesses a e indica ed 922 by he blue a ows. (E) KEGG pa hway analyses o deple ed egions o bo h his one ma ks. Dashed 923 g ey line indica es he signi ican adjus ed p- alue <0.05. (F) Func ional p o ein-p o ein ne wo k 924 analysis (STRING) ep esen a ion o insulin and glucagon- ela ed genes ound dec eased in bo h 925 his one ace yla ion ma ks. (G) Rep esen a ion o he genomic egions (IGV) o he me abolic genes 926 I s1 and Gsk3b showing signi ican dec ease o H3K27ac and H3K9/14ac a e ca eine ea men 927 (I s1 H3K27ac FDR=1.82E-12; H3K9/14ac FDR=7.75E-05; Gsk3b H3K27ac FDR=4.83E-05; 928 H3K9/14ac FDR=2.58E-11). Two biological eplica es pe his one ma k we e used o ChIP-seq 929 expe imen s. 930 931 39 932 933 934 935 936 937 938 939 940 40 Figu e 2. Hippocampal me abolomic changes induced by ch onic ca eine consump ion. 941 Unsupe ised p incipal componen analysis (PCA) pe o med in he hippocampal egion o in e es 942 delimi a ed in yellow on he Nissl s aining o he b ain issue sec ion (A). Sco es om he 943 unsupe ised PCA in he hippocampus o Wa e - (in blue) and Ca eine- ea ed mice (in ed) a e 944 p esen ed in a plo whe e he di e ences be ween he molecula signa u es o he wo expe imen al 945 g oups clea ly eme ge (B). Pie cha s showing he dis ibu ion o he di e en classes o molecules 946 (C) and hei abundance changes (D) o m/z measu ed in posi i e o nega i e ioniza ion modes wi h 947 a signi ican quan i a i e di e ence a e he S uden ’s - es analysis in he hippocampus o Ca eine- 948 compa ed o Wa e - ea ed animals (N = 6/g oup). (E) Mass spec ome y images ob ained a a 949 spa ial esolu ion o 35 µm o m/z p esen ing a dec eased (g een) o inc eased (o ange) densi y in 950 he hippocampus o Ca eine- ea ed compa ed o Wa e - ea ed mice. The colo scale shows he 951 in ensi y o he m/z o in e es . Ce , ce amide; PC, phospha idylcholine; PI, phospha idylinosi ol; PS, 952 phospha idylse ine. 953 954 955 956 957 958 959 960 41 961 962 963 964 965 966 967 968 969